Global /Canada /Healthcare /Drug Manufacturers - General /GREY

Grey Matters Health Inc.

GREY

• CSE: GREY • Delayed

0.3500CAD -6.7%

0.2508 USD

As of 10 June 2026, Grey Matters Health Inc. has a market cap of $1.46M USD, ranking #47827 globally and #2569 in Canada. It ranks #4244 in the Healthcare sector, and #1344 in the Drug Manufacturers - General industry.

Global Rank

47827

Country Rank

2569

Sector Rank

4244

Industry Rank

1344

Key Stats

Market Cap

$1.46MUSD

2.03M CAD

Enterprise Value

$2.03MUSD

2.84M CAD

EBITDA (TTM)

-$1.23MUSD

-1.71M CAD

Net Income (TTM)

-$1.39MUSD

-1.93M CAD

PB Ratio

0.8

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Christopher Moreau open_in_new

Founded

2015

Website

algernonhealth.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-6.7%	-24%	-25%	-25%	-56%	-38%	-56%	-86%	-99%

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	GREY ISIN: CA3978841078 Shares Out.: Shares Outstanding: 5.418M¹ Shares Float: 4.902M² TV: TradingView: CSE: GREY SA: Stock Analysis: CSE: GREY YF: Yahoo Finance: GREY.CN GF: Google Finance: CNSX: GREY BA: Barron's: GREY MS: Morningstar: XCNQ: GREY	0.3500 CAD	TV: TradingView: CSE: GREY SA: Stock Analysis: CSE: GREY YF: Yahoo Finance: GREY.CN GF: Google Finance: CNSX: GREY BA: Barron's: GREY MS: Morningstar: XCNQ: GREY
Cboe Canada (NEO) MIC: NEOE	GREY ISIN: CA3978841078 TV: TradingView: NEO: GREY SA: Stock Analysis: NEO: GREY YF: Yahoo Finance: GREY.NE GF: Google Finance: NEO: GREY BA: Barron's: GREY MS: Morningstar: NEOE: GREY	0.4350 CAD	TV: TradingView: NEO: GREY SA: Stock Analysis: NEO: GREY YF: Yahoo Finance: GREY.NE GF: Google Finance: NEO: GREY BA: Barron's: GREY MS: Morningstar: NEOE: GREY
OTC Markets (OTCMKTS / OTC) MIC: OTCM	AGNPD ISIN: CA3978841078 TV: TradingView: OTC: AGNPD SA: Stock Analysis: OTC: AGNPD YF: Yahoo Finance: AGNPD GF: Google Finance: OTCMKTS: AGNPD BA: Barron's: AGNPD MS: Morningstar: PINX: AGNPD	0.2703 USD	TV: TradingView: OTC: AGNPD SA: Stock Analysis: OTC: AGNPD YF: Yahoo Finance: AGNPD GF: Google Finance: OTCMKTS: AGNPD BA: Barron's: AGNPD MS: Morningstar: PINX: AGNPD

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Grey Matters Health Inc.

Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Similar Companies

Industry: Drug Manufacturers - General (Canada)

Name	Market Cap (USD) diff.	PE	Country
Xenon Pharmaceuticals Inc. NASDAQ: XENE	$5.39B 370K%	-	Canada
Knight Therapeutics Inc. TSX: GUD	$519.69M 725.1M CAD 36K%	-	Canada
Milestone Pharmaceuticals Inc. NASDAQ: MIST	$223.22M 15K%	-	Canada
Satellos Bioscience Inc. TSX: MSCL	$155.42M 216.85M CAD 11K%	-	Canada
BioSyent Inc. TSXV: RX	$118.87M 165.86M CAD 8K%	18.5	Canada
Helix BioPharma Corp. TSX: HBP	$110.58M 154.28M CAD 7K%	-	Canada

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 52M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 38M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 25M%	97.4	United States
Roche Holding AG SIX: RO	$321.17B 256.25B CHF 22M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.57B 215.59B GBP 20M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.35B 218.9B CHF 19M%	20.5	Switzerland

chevron_leftBack